Skip to main content
Erschienen in: Supportive Care in Cancer 9/2017

06.06.2017 | Review Article

Influential factors on treatment decision making among patients with colorectal cancer: A scoping review

verfasst von: Nicole M. Cranley, Barbara Curbow, Thomas J. George Jr., Juliette Christie

Erschienen in: Supportive Care in Cancer | Ausgabe 9/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

In recent years, a greater emphasis has been placed on shared decision-making (SDM) techniques between providers and patients with the goal of helping patients make informed decisions about their care and subsequently to improve patient health outcomes. Previous research has shown variability in treatment decision-making among patients with colorectal cancer (CRC), and there is little comprehensive information available to help explain this variability. Thus, the purpose of this study was to evaluate the current state of the literature on factors that are influential in treatment decision-making among patients with CRC.

Method

A priori search terms using Boolean connectors were used to examine PubMed, PsycINFO, Web of Science, CINAHL, and MEDLINE for relevant studies. Eligibility criteria for inclusion in the study included patients with CRC and examination of influences on CRC treatment decision-making. All relevant data were extracted including, author, title and year, study methodology, and study results.

Results

Findings (n = 13) yielded influences in four areas: informational, patient treatment goals, patient role preferences, and relationship with provider. Quality of life and trust in physician were rated a high priority among patients when making decisions between different therapeutic options. Several studies found that patients wanted to be informed and involved but did not necessarily want to make autonomous treatment choices, with many preferring a more passive role.

Conclusions

Providers who initiate a dialog to better understand their patients’ treatment goals can establish rapport, increase patient understanding of treatment options, and help patients assume their desired role in their decision-making. Overall, there were a small number of studies that met all inclusion criteria with most used a cross-sectional design.
Literatur
1.
Zurück zum Zitat Beaver K, Bogg J, Luker KA (1999) Decision-making role preferences and information needs: a comparison of colorectal and breast cancer. Health Expect 2:266–276CrossRefPubMedPubMedCentral Beaver K, Bogg J, Luker KA (1999) Decision-making role preferences and information needs: a comparison of colorectal and breast cancer. Health Expect 2:266–276CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Beaver K, Campbell M, Craven O, Jones D, Luker KA, Susnerwala SS (2009) Colorectal cancer patients’ attitudes towards involvement in decision making. Health Expect 12:27–37CrossRefPubMedPubMedCentral Beaver K, Campbell M, Craven O, Jones D, Luker KA, Susnerwala SS (2009) Colorectal cancer patients’ attitudes towards involvement in decision making. Health Expect 12:27–37CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Beaver K, Craven O, Witham G, Tomlinson M, Susnerwala S, Jones D, Luker KA (2007) Patient participation in decision making: views of health professionals caring for people with colorectal cancer. J Clin Nurs 16:725–733CrossRefPubMed Beaver K, Craven O, Witham G, Tomlinson M, Susnerwala S, Jones D, Luker KA (2007) Patient participation in decision making: views of health professionals caring for people with colorectal cancer. J Clin Nurs 16:725–733CrossRefPubMed
4.
Zurück zum Zitat Beaver K, Jones D, Susnerwala S, Craven O, Tomlinson M, Witham G, Luker KA (2005) Exploring the decision-making preferences of people with colorectal cancer. Health Expect 8:103–113CrossRefPubMedPubMedCentral Beaver K, Jones D, Susnerwala S, Craven O, Tomlinson M, Witham G, Luker KA (2005) Exploring the decision-making preferences of people with colorectal cancer. Health Expect 8:103–113CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Berry J, Bumpers K, Ogunlade V, Glover R, Davis S, Counts-Spriggs M, Kauh J, Flowers C (2009) Examining racial disparities in colorectal cancer care. J Psychosoc Oncol 27:59–83CrossRefPubMed Berry J, Bumpers K, Ogunlade V, Glover R, Davis S, Counts-Spriggs M, Kauh J, Flowers C (2009) Examining racial disparities in colorectal cancer care. J Psychosoc Oncol 27:59–83CrossRefPubMed
6.
Zurück zum Zitat Berry J, Caplan L, Davis S, Minor P, Counts-Spriggs M, Glover R, Ogunlade V, Bumpers K, Kauh J, Brawley OW, Flowers C (2010) A black-white comparison of the quality of stage-specific colon cancer treatment. Cancer 116:713–722CrossRefPubMedPubMedCentral Berry J, Caplan L, Davis S, Minor P, Counts-Spriggs M, Glover R, Ogunlade V, Bumpers K, Kauh J, Brawley OW, Flowers C (2010) A black-white comparison of the quality of stage-specific colon cancer treatment. Cancer 116:713–722CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Busch EL, Martin C, DeWalt DA, Sandler RS (2015) Functional health literacy, chemotherapy decisions, and outcomes among a colorectal cancer cohort. Cancer Control 22:95–101PubMedPubMedCentral Busch EL, Martin C, DeWalt DA, Sandler RS (2015) Functional health literacy, chemotherapy decisions, and outcomes among a colorectal cancer cohort. Cancer Control 22:95–101PubMedPubMedCentral
8.
Zurück zum Zitat Chagpar R, Xing Y, Chiang YJ, Feig BW, Chang GJ, You YN, Cormier JN (2012) Adherence to stage-specific treatment guidelines for patients with colon cancer. J Clin Oncol 30:972–979CrossRefPubMedPubMedCentral Chagpar R, Xing Y, Chiang YJ, Feig BW, Chang GJ, You YN, Cormier JN (2012) Adherence to stage-specific treatment guidelines for patients with colon cancer. J Clin Oncol 30:972–979CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Charles C, Gafni A, Whelan T (2000) How to improve communication between doctors and patients. Learning more about the decision making context is important. BMJ 320:1220–1221CrossRefPubMedPubMedCentral Charles C, Gafni A, Whelan T (2000) How to improve communication between doctors and patients. Learning more about the decision making context is important. BMJ 320:1220–1221CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Degner LF, Sloan JA, Venkatesh P (1997) The Control Preferences Scale. Can J Nurs Res 29:21–43PubMed Degner LF, Sloan JA, Venkatesh P (1997) The Control Preferences Scale. Can J Nurs Res 29:21–43PubMed
11.
Zurück zum Zitat Dijkers M (2015) What is a scoping review? In: editor (ed)^(eds) Book what is a scoping review? Center on knowledge translation for disability and rehabilitation Research, City. Dijkers M (2015) What is a scoping review? In: editor (ed)^(eds) Book what is a scoping review? Center on knowledge translation for disability and rehabilitation Research, City.
12.
Zurück zum Zitat Du XL, Fang S, Vernon SW, El-Serag H, Shih YT, Davila J, Rasmus ML (2007) Racial disparities and socioeconomic status in association with survival in a large population-based cohort of elderly patients with colon cancer. Cancer 110:660–669CrossRefPubMed Du XL, Fang S, Vernon SW, El-Serag H, Shih YT, Davila J, Rasmus ML (2007) Racial disparities and socioeconomic status in association with survival in a large population-based cohort of elderly patients with colon cancer. Cancer 110:660–669CrossRefPubMed
13.
Zurück zum Zitat Elkin EB, Kim SH, Casper ES, Kissane DW, Schrag D (2007) Desire for information and involvement in treatment decisions: elderly cancer patients’ preferences and their physicians’ perceptions. J Clin Oncol 25:5275–5280CrossRefPubMed Elkin EB, Kim SH, Casper ES, Kissane DW, Schrag D (2007) Desire for information and involvement in treatment decisions: elderly cancer patients’ preferences and their physicians’ perceptions. J Clin Oncol 25:5275–5280CrossRefPubMed
14.
Zurück zum Zitat Fallowfield LJ (2008) Treatment decision-making in breast cancer: the patient-doctor relationship. Breast Cancer Res Treat 112(Suppl 1):5–13CrossRefPubMed Fallowfield LJ (2008) Treatment decision-making in breast cancer: the patient-doctor relationship. Breast Cancer Res Treat 112(Suppl 1):5–13CrossRefPubMed
15.
Zurück zum Zitat Fu AZ, Graves KD, Jensen RE, Marshall JL, Formoso M, Potosky AL (2015) Patient preference and decision-making for initiating metastatic colorectal cancer medical treatment. J Cancer Res Clin Oncol Fu AZ, Graves KD, Jensen RE, Marshall JL, Formoso M, Potosky AL (2015) Patient preference and decision-making for initiating metastatic colorectal cancer medical treatment. J Cancer Res Clin Oncol
16.
Zurück zum Zitat Hofmann S, Vetter J, Wachter C, Henne-Bruns D, Porzsolt F, Kornmann M (2012) Visual AIDS for multimodal treatment options to support decision making of patients with colorectal cancer. BMC Med Inform Decis Mak 12:118CrossRefPubMedPubMedCentral Hofmann S, Vetter J, Wachter C, Henne-Bruns D, Porzsolt F, Kornmann M (2012) Visual AIDS for multimodal treatment options to support decision making of patients with colorectal cancer. BMC Med Inform Decis Mak 12:118CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Institute NC SEER Cancer statistics factsheets: colon and rectum cancer. In: editor (ed)^(eds) book SEER cancer statistics factsheets: colon and Rectum cancer, City Institute NC SEER Cancer statistics factsheets: colon and rectum cancer. In: editor (ed)^(eds) book SEER cancer statistics factsheets: colon and Rectum cancer, City
18.
Zurück zum Zitat Jorgensen ML, Young JM, Solomon MJ (2013) Adjuvant chemotherapy for colorectal cancer: age differences in factors influencing patients’ treatment decisions. Patient Prefer Adherence 7:827–834CrossRefPubMedPubMedCentral Jorgensen ML, Young JM, Solomon MJ (2013) Adjuvant chemotherapy for colorectal cancer: age differences in factors influencing patients’ treatment decisions. Patient Prefer Adherence 7:827–834CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Levac D, Colquhoun H, O’Brien K (2010) Scoping studies: advancing the methodology. Implement Sci 5:19CrossRef Levac D, Colquhoun H, O’Brien K (2010) Scoping studies: advancing the methodology. Implement Sci 5:19CrossRef
21.
Zurück zum Zitat Mack JW, Cronin A, Fasciano K, Block SD, Keating NL (2015) Cancer treatment decision-making among young adults with lung and colorectal cancer: a comparison with adults in middle age. Psychooncology Mack JW, Cronin A, Fasciano K, Block SD, Keating NL (2015) Cancer treatment decision-making among young adults with lung and colorectal cancer: a comparison with adults in middle age. Psychooncology
22.
Zurück zum Zitat Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339:b2535CrossRefPubMedPubMedCentral Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339:b2535CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Mott-Coles S (2014) Patients’ cultural beliefs in patient-provider communication with African American women and Latinas diagnosed with breast cancer. Clin J Oncol Nurs 18:443–448CrossRefPubMed Mott-Coles S (2014) Patients’ cultural beliefs in patient-provider communication with African American women and Latinas diagnosed with breast cancer. Clin J Oncol Nurs 18:443–448CrossRefPubMed
24.
Zurück zum Zitat Ramfelt E, Lützen K, Nordström G (2005) Treatment decision-making in a group of patients with colo-rectal cancer before surgery and a one-year follow-up. Eur J Cancer Care (Engl) 14:327–335CrossRef Ramfelt E, Lützen K, Nordström G (2005) Treatment decision-making in a group of patients with colo-rectal cancer before surgery and a one-year follow-up. Eur J Cancer Care (Engl) 14:327–335CrossRef
25.
Zurück zum Zitat Ramfelt E, Lützén K (2005) Patients with cancer: their approaches to participation in treatment plan decisions. Nurs Ethics 12:143–155CrossRefPubMed Ramfelt E, Lützén K (2005) Patients with cancer: their approaches to participation in treatment plan decisions. Nurs Ethics 12:143–155CrossRefPubMed
26.
Zurück zum Zitat Sahay TB, Gray RE, Fitch M (2000) A qualitative study of patient perspectives on colorectal cancer. Cancer Pract 8:38–44CrossRefPubMed Sahay TB, Gray RE, Fitch M (2000) A qualitative study of patient perspectives on colorectal cancer. Cancer Pract 8:38–44CrossRefPubMed
27.
Zurück zum Zitat Sajid MS, Shakir AJ, Baig MK (2011) Information on the Internet about colorectal cancer: patient attitude and potential toward web browsing. A prospective observational study. Can J Surg 54:339–343CrossRefPubMedPubMedCentral Sajid MS, Shakir AJ, Baig MK (2011) Information on the Internet about colorectal cancer: patient attitude and potential toward web browsing. A prospective observational study. Can J Surg 54:339–343CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Salkeld G, Solomon M, Short L, Butow P (2004) A matter of trust—patient’s views on decision-making in colorectal cancer. Health Expectations 7:104–114CrossRefPubMedPubMedCentral Salkeld G, Solomon M, Short L, Butow P (2004) A matter of trust—patient’s views on decision-making in colorectal cancer. Health Expectations 7:104–114CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Sanders T, Skevington S (2003) Do bowel cancer patients participate in treatment decision-making? Findings from a qualitative study. Eur J Cancer Care (Engl) 12:166–175CrossRef Sanders T, Skevington S (2003) Do bowel cancer patients participate in treatment decision-making? Findings from a qualitative study. Eur J Cancer Care (Engl) 12:166–175CrossRef
30.
Zurück zum Zitat Singh JA, Sloan JA, Atherton PJ, Smith T, Hack TF, Huschka MM, Rummans TA, Clark MM, Diekmann B, Degner LF (2010) Preferred roles in treatment decision making among patients with cancer: a pooled analysis of studies using the Control Preferences Scale. Am J Manag Care 16:688–696PubMedPubMedCentral Singh JA, Sloan JA, Atherton PJ, Smith T, Hack TF, Huschka MM, Rummans TA, Clark MM, Diekmann B, Degner LF (2010) Preferred roles in treatment decision making among patients with cancer: a pooled analysis of studies using the Control Preferences Scale. Am J Manag Care 16:688–696PubMedPubMedCentral
31.
Zurück zum Zitat Snijders HS, Kunneman M, Bonsing BA, de Vries AC, Tollenaar RA, Pieterse AH, Stiggelbout AM (2014) Preoperative risk information and patient involvement in surgical treatment for rectal and sigmoid cancer. Colorectal Dis 16:O43–O49CrossRefPubMed Snijders HS, Kunneman M, Bonsing BA, de Vries AC, Tollenaar RA, Pieterse AH, Stiggelbout AM (2014) Preoperative risk information and patient involvement in surgical treatment for rectal and sigmoid cancer. Colorectal Dis 16:O43–O49CrossRefPubMed
32.
Zurück zum Zitat Tejeda S, Darnell JS, Cho YI, Stolley MR, Markossian TW, Calhoun EA (2013) Patient barriers to follow-up care for breast and cervical cancer abnormalities. J Women’s Health (Larchmt) 22:507–517CrossRef Tejeda S, Darnell JS, Cho YI, Stolley MR, Markossian TW, Calhoun EA (2013) Patient barriers to follow-up care for breast and cervical cancer abnormalities. J Women’s Health (Larchmt) 22:507–517CrossRef
33.
Zurück zum Zitat van der Heide I, Rademakers J, Schipper M, Droomers M, Sørensen K, Uiters E (2013) Health literacy of Dutch adults: a cross sectional survey. BMC Public Health 13:179CrossRefPubMedPubMedCentral van der Heide I, Rademakers J, Schipper M, Droomers M, Sørensen K, Uiters E (2013) Health literacy of Dutch adults: a cross sectional survey. BMC Public Health 13:179CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Wong AC, Stock S, Schrag D, Kahn KL, Salz T, Charlton ME, Rogers SO, Goodman KA, Keating NL (2014) Physicians’ beliefs about the benefits and risks of adjuvant therapies for stage II and stage III colorectal cancer. J Oncol Pract Wong AC, Stock S, Schrag D, Kahn KL, Salz T, Charlton ME, Rogers SO, Goodman KA, Keating NL (2014) Physicians’ beliefs about the benefits and risks of adjuvant therapies for stage II and stage III colorectal cancer. J Oncol Pract
Metadaten
Titel
Influential factors on treatment decision making among patients with colorectal cancer: A scoping review
verfasst von
Nicole M. Cranley
Barbara Curbow
Thomas J. George Jr.
Juliette Christie
Publikationsdatum
06.06.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 9/2017
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-017-3763-z

Weitere Artikel der Ausgabe 9/2017

Supportive Care in Cancer 9/2017 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.